Transcriptional Upregulation of HER2 Expression in the Absence of HER2 Gene Amplification Results in Cetuximab Resistance That Is Reversed by Trastuzumab Treatment

Oncology Reports - Greece
doi 10.3892/or.2012.1732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis

Modern Pathology
Forensic MedicinePathology
2010English

Gene Amplification and Overexpression of HER2 in Renal Cell Carcinoma

BJU International
Urology
2008English

Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma

Clinical Breast Cancer
Cancer ResearchOncology
2013English

HER2/neu (ERBB2) Expression and Gene Amplification Correlates With Better Survival in Esophageal Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

HER2 Genomic Amplification in Circulating Tumor DNA From Patients With Cetuximab-Resistant Colorectal Cancer

Oncotarget
Oncology
2015English

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Clinical Cancer Research
Cancer ResearchOncology
2011English

Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2014English

Cisplatin Resistance in Gastric Cancer Cells Is Associated With HER2 Upregulation-Induced Epithelial-Mesenchymal Transition

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy